Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials
- PMID: 23029567
- PMCID: PMC3459884
- DOI: 10.1371/journal.pntd.0001752
Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials
Conflict of interest statement
The authors have read the journal's policy and have the following conflicts. Rosemary Petric is an employee of Hoffmann-La Roche, USA. Pei-Yong Shi is an employee of the Novartis Institute of Tropical Diseases, Singapore. Cameron Simmons is a consultant to Unither Virology LLC. The corresponding author (CPS) takes responsibility for the content of this paper and the decision to submit for publication.
Figures
References
-
- Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, et al. (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4: e785 doi:10.1371/journal.pntd.0000785. - DOI - PMC - PubMed
-
- Simmons CP, Farrar JJ, Nguyen vV, Wills B (2012) Dengue. N Engl J Med 366: 1423–1432. - PubMed
-
- Halstead SB (2007) Dengue. Lancet 370: 1644–1652. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical